Universe Pharmaceuticals (UPC) Cash & Current Investments: 2020-2024
- Universe Pharmaceuticals' Cash & Current Investments rose 364.13% to $30.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $64.4 million, marking a year-over-year decrease of 3.87%. This contributed to the annual value of $30.9 million for FY2024, which is 364.13% up from last year.
- As of Q3 2024, Universe Pharmaceuticals' Cash & Current Investments stood at $30.9 million, which was up 295.19% from $7.8 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Cash & Current Investments registered a high of $30.9 million during Q3 2024, and its lowest value of $6.7 million during Q3 2023.
- Its 3-year average for Cash & Current Investments is $17.6 million, with a median of $18.9 million in 2022.
- Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 64.73% in 2023, then soared by 364.13% in 2024.
- Universe Pharmaceuticals' Cash & Current Investments (Quarterly) stood at $10.1 million in 2020, then skyrocketed by 116.77% to $21.8 million in 2021, then fell by 13.50% to $18.9 million in 2022, then plummeted by 64.73% to $6.7 million in 2023, then skyrocketed by 364.13% to $30.9 million in 2024.
- Its Cash & Current Investments stands at $30.9 million for Q3 2024, versus $7.8 million for Q1 2024 and $6.7 million for Q3 2023.
